Substituted quinazolines as antiviral agents, especially against cytomegaloviruses

US7709491B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Tobias Wunberg · Mödling, AT
• Judith Baumeister · Wuppertal, DE
• Mario Jeske · Solingen, DE
• Susanne Nikolic · Monheim, DE
• Frank Süβmeier · Birkenfeld, DE
• Holger Zimmermann · Falkensee, DE
• Rolf Grosser · Schwandorf, DE
• Kerstin Henninger · Wuppertal, DE
• Guy Hewlett · Wuppertal, DE
• Jörg Keldenich · Wuppertal, DE
• Dieter Lang · Velbert, DE
• Tse-I Lin · Mechelen, BE

Key dates

• Filing date: Oct 25, 2003
• Grant date: May 4, 2010
• Expiry date: Aug 22, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/22
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted quinazolines and to methods for the production thereof, in addition to the use thereof in the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.